- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01275378
Comparative Effectiveness Research for Two Medical Home Models for Attention Deficit Hyperactivity Disorder
October 7, 2016 updated by: Michael Silverstein, Boston Medical Center
COMPARATIVE EFFECTIVENESS RESEARCH FOR TWO MEDICAL HOME MODELS FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER
The purpose of this study is to compare the effectiveness of two care models on ADHD outcomes: one, a model of basic care management and structured communication with specialists, consistent with conventional descriptions of a patient-centered Medical Home; and another, which combines the Medical Home with theory-based care management strategies to address common reasons for ADHD treatment failure.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
156
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Boston Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 12 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Child is being evaluated for a potential diagnosis of ADHD by a primary care pediatrician at one of our sites.
- Child is 6 to 12 years of age
- Family plans to remain in the Boston area for the duration of the follow-up period
- Mother is comfortable in English or Spanish
Exclusion Criteria:
- Child already has a confirmed diagnosis of ADHD
- Child already receives ongoing specialty care in one or more of the following clinics: pediatric psychiatry, developmental behavioral pediatrics
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Collaborative Care Plus
Collaborative care model with specific theory-based elements to address common reasons for ADHD treatment failure
|
Traditional collaborative care + systematic addressing of ADHD comorbidities, parental mental health issues, and adherence to treatment plans
|
ACTIVE_COMPARATOR: Traditional Collaborative Care
Traditional collaborative care, in which care managers serve as intermediaries between primary care physicians and specialists
|
Traditional collaborative care, in which care managers serve as intermediaries between primary care physicians and specialists
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ADHD Symptoms
Time Frame: 6 mo
|
Swanson, Nolan and Pelham scale (SNAP-IV)
|
6 mo
|
ADHD Symptoms
Time Frame: 12 mo
|
Swanson, Nolan and Pelham scale (SNAP-IV)
|
12 mo
|
Patient Medication Adherence
Time Frame: 6 mo
|
Timely prescribed refills of ADHD medications - assessed through the EHR - will provide an accurate picture of medication adherence from the perspective of prescription writing.
In addition, we will administer the validated Medication Adherence Scale, which has good reliability among parents of urban children with asthma
|
6 mo
|
Patient Medication Adherence
Time Frame: 12 mo
|
Timely prescribed refills of ADHD medications - assessed through the EHR - will provide an accurate picture of medication adherence from the perspective of prescription writing.
In addition, we will administer the validated Medication Adherence Scale, which has good reliability among parents of urban children with asthma
|
12 mo
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ODD Symptoms
Time Frame: 6 mo
|
SNAP-IV
|
6 mo
|
Social Skills
Time Frame: 6 mo
|
Social Skills Rating System
|
6 mo
|
Time to Symptom Improvement
Time Frame: 12 mo
|
Based on follow-up ADHD symptom scales administered at regular intervals by our care managers, we will quantify the time between initial diagnosis and definitive improvement - conventionally defined by a 25% symptom reduction from baseline
|
12 mo
|
ODD Symptoms
Time Frame: 12 mo
|
SNAP-IV
|
12 mo
|
Social Skills
Time Frame: 12 mo
|
Social Skills Rating System
|
12 mo
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (ACTUAL)
June 1, 2014
Study Completion (ACTUAL)
June 1, 2014
Study Registration Dates
First Submitted
October 11, 2010
First Submitted That Met QC Criteria
January 11, 2011
First Posted (ESTIMATE)
January 12, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
October 10, 2016
Last Update Submitted That Met QC Criteria
October 7, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R40MC17181
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Attention Deficit/Hyperactivity Disorder
-
Cingulate TherapeuticsRecruitingPhase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Ornit CohenUnknownAttention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersIsrael
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Children's National Research InstituteRecruitingADHD | Attention Deficit Hyperactivity Disorder | Attention-Deficit Hyperactivity Disorder | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - Impulsive | Attention-Deficit Disorder in Adolescence | Attention-Deficit Hyperactivity...United States
-
Fondation LenvalCompletedAttention Deficit Disorder With Hyperactivity | Attention Deficit Disorder Without HyperactivityFrance
-
University Hospital Bispebjerg and FrederiksbergMental Health Services in the Capital Region, DenmarkRecruitingSleep Disturbance | Neurodevelopmental Disorders | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder | Attention-Deficit Hyperactivity Disorder, Unspecified Type | Attention-deficit Hyperactivity | Hyperkinetic Conduct DisorderDenmark
-
Corium, Inc.Worldwide Clinical Trials; Premier Research Group plc; Almac; Prometrika, LLCRecruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Corium, Inc.Premier Research Group plc; Almac; Prometrika, LLCActive, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Massachusetts General HospitalShire Human Genetic Therapies, Inc.Active, not recruitingAttention Deficit/Hyperactivity DisorderUnited States
-
Ataturk UniversityCompletedAttention-deficit/Hyperactivity DisorderTurkey
Clinical Trials on Collaborative Care Plus
-
Major Extremity Trauma Research ConsortiumCompletedSevere Orthopedic TraumaUnited States
-
University of ArkansasCompleted
-
University of PittsburghNational Institute of Mental Health (NIMH)CompletedDepression | Generalized Anxiety Disorder | Panic DisorderUnited States
-
RANDNational Institute of Mental Health (NIMH); University of Pittsburgh; Boston... and other collaboratorsActive, not recruitingDepression | Suicidal Ideation | Addiction | Post Traumatic Stress Disorder | Opioid-use DisorderUnited States
-
Seattle Children's HospitalCompletedDepression | Anxiety | TBI | Concussion, BrainUnited States
-
University of UtahRobert Wood Johnson FoundationCompletedChild Abuse | Primary Health Care | Child WelfareUnited States
-
University of WashingtonNational Institute on Disability, Independent Living, and Rehabilitation...CompletedChronic Pain | Brain Injuries, Traumatic | Post-Traumatic HeadacheUnited States
-
University of PittsburghCompletedDepression | Pain | Kidney TransplantUnited States
-
National University of SingaporeCompleted
-
Washington University School of MedicineAgency for Healthcare Research and Quality (AHRQ)CompletedDepression | Coronary Heart DiseaseUnited States